1 patient evaluation for Obinutuzumab

Aug 26, 2017 (Started Feb 28, 2017)

  • Effectiveness
    Can't tell (for follicular lymphoma)
  • Side effects
    Moderate (nausea)
  • Adherence
  • Burden
    Somewhat hard to take
Dosage: 25 mg Every 3 months
Advice & Tips: Currently on hold with this treatment. Side effects of Bendeka/Gazyva have been so severe I had to srop both. I have had one treatment with Gazyva alone with inconclusive results. If and when I recover from the Bendeka side effects, I will likely try Gazyva again.

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Obinutuzumab